...
search icon
abeo-img

Abeona Therapeutics Inc Share Price

ABEO
NAQ
$5.01
+$0.02
(0.4%)
1D
Industry: Biotechnology Sector: Health Care

Abeona Therapeutics Inc Analyst Forecast

Abeona Therapeutics Inc Share Price Chart

Abeona Therapeutics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$270.41M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
4.124
Volume info-icon
This is the total number of shares traded during the most recent trading day.
437.16K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.13
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.93 L
$7.54 H
$5.01

About Abeona Therapeutics Inc, Common Stock

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio. more

Industry: BiotechnologySector: Health Care

Abeona Therapeutics Inc Stock Returns

Time FrameABEOSectorS&P500
1-Week Return-2.73%-1.08%-1.38%
1-Month Return-1.96%-0.47%-1.81%
3-Month Return10.15%2.13%1.38%
6-Month Return-23.93%17.04%5.68%
1-Year Return-15.85%6.56%11.74%
3-Year Return103.67%16.78%65.15%
5-Year Return-92.66%34.34%73.68%
10-Year Return-91.98%137.88%260.03%

Abeona Therapeutics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue10.00M3.00M1.41M3.50M-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":30,"profit":true},{"date":"2022-12-31","value":14.14,"profit":true},{"date":"2023-12-31","value":35,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue30.14M38.73M450.00K1.60M2.91M[{"date":"2020-12-31","value":77.83,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":1.16,"profit":true},{"date":"2023-12-31","value":4.14,"profit":true},{"date":"2024-12-31","value":7.51,"profit":true}]
Gross Profit10.00M3.00M964.00K1.90M(2.91M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":30,"profit":true},{"date":"2022-12-31","value":9.64,"profit":true},{"date":"2023-12-31","value":18.95,"profit":true},{"date":"2024-12-31","value":-29.07,"profit":false}]
Gross Margin100.00%100.00%68.18%54.14%-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":68.18,"profit":true},{"date":"2023-12-31","value":54.14,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses91.42M92.84M51.88M49.03M61.30M[{"date":"2020-12-31","value":98.47,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":55.88,"profit":true},{"date":"2023-12-31","value":52.81,"profit":true},{"date":"2024-12-31","value":66.03,"profit":true}]
Operating Income(81.42M)(89.84M)(50.91M)(47.13M)(64.21M)[{"date":"2020-12-31","value":-8142000000,"profit":false},{"date":"2021-12-31","value":-8983600000,"profit":false},{"date":"2022-12-31","value":-5091500000,"profit":false},{"date":"2023-12-31","value":-4713500000,"profit":false},{"date":"2024-12-31","value":-6421100000,"profit":false}]
Total Non-Operating Income/Expense(5.63M)1.30M10.91M(5.35M)515.00K[{"date":"2020-12-31","value":-51.57,"profit":false},{"date":"2021-12-31","value":11.9,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-49.06,"profit":false},{"date":"2024-12-31","value":4.72,"profit":true}]
Pre-Tax Income(84.23M)(84.94M)(39.70M)(54.19M)(63.73M)[{"date":"2020-12-31","value":-8423400000,"profit":false},{"date":"2021-12-31","value":-8493600000,"profit":false},{"date":"2022-12-31","value":-3969600000,"profit":false},{"date":"2023-12-31","value":-5418800000,"profit":false},{"date":"2024-12-31","value":-6373400000,"profit":false}]
Income Taxes4.12M3.67M(7.89M)3.03M-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":89.19,"profit":true},{"date":"2022-12-31","value":-191.66,"profit":false},{"date":"2023-12-31","value":73.64,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(88.35M)(88.61M)(31.81M)(57.22M)-[{"date":"2020-12-31","value":-8834900000,"profit":false},{"date":"2021-12-31","value":-8860600000,"profit":false},{"date":"2022-12-31","value":-3180900000,"profit":false},{"date":"2023-12-31","value":-5721810500,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(84.23M)(84.94M)(39.70M)(54.19M)(63.73M)[{"date":"2020-12-31","value":-8423400000,"profit":false},{"date":"2021-12-31","value":-8493600000,"profit":false},{"date":"2022-12-31","value":-3969600000,"profit":false},{"date":"2023-12-31","value":-5418800000,"profit":false},{"date":"2024-12-31","value":-6373400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(84.23M)(84.94M)(39.70M)(54.19M)(63.73M)[{"date":"2020-12-31","value":-8423400000,"profit":false},{"date":"2021-12-31","value":-8493600000,"profit":false},{"date":"2022-12-31","value":-3969600000,"profit":false},{"date":"2023-12-31","value":-5418800000,"profit":false},{"date":"2024-12-31","value":-6373400000,"profit":false}]
EPS (Diluted)(13.75)(15.75)(5.53)(2.71)(1.60)[{"date":"2020-12-31","value":-1375,"profit":false},{"date":"2021-12-31","value":-1575,"profit":false},{"date":"2022-12-31","value":-553,"profit":false},{"date":"2023-12-31","value":-271,"profit":false},{"date":"2024-12-31","value":-160.02,"profit":false}]

Abeona Therapeutics Inc Ratios

Abeona Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

ABEO
Cash Ratio 9.35
Current Ratio 9.74
Quick Ratio 9.53

Abeona Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ABEO
ROA (LTM) -29.58%
ROE (LTM) 75.90%

Abeona Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ABEO
Debt Ratio Lower is generally better. Negative is bad. 0.26
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.74

Abeona Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ABEO
Trailing PE 4.12
Forward PE 500.00
P/S (TTM) 676.04
P/B 1.58
Price/FCF NM
EV/R 219.87
EV/Ebitda 0.98
PEG NM

FAQs

What is Abeona Therapeutics Inc share price today?

Abeona Therapeutics Inc (ABEO) share price today is $5.01

Can Indians buy Abeona Therapeutics Inc shares?

Yes, Indians can buy shares of Abeona Therapeutics Inc (ABEO) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ABEO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Abeona Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Abeona Therapeutics Inc (ABEO) via the Vested app. You can start investing in Abeona Therapeutics Inc (ABEO) with a minimum investment of $1.

How to invest in Abeona Therapeutics Inc shares from India?

You can invest in shares of Abeona Therapeutics Inc (ABEO) via Vested in three simple steps:

  • Click on Sign Up or Invest in ABEO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Abeona Therapeutics Inc shares
What is Abeona Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Abeona Therapeutics Inc (ABEO) is $7.54. The 52-week low price of Abeona Therapeutics Inc (ABEO) is $3.93.

What is Abeona Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Abeona Therapeutics Inc (ABEO) is 4.124

What is Abeona Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Abeona Therapeutics Inc (ABEO) is 1.58

What is Abeona Therapeutics Inc dividend yield?

The dividend yield of Abeona Therapeutics Inc (ABEO) is 0.00%

What is the Market Cap of Abeona Therapeutics Inc?

The market capitalization of Abeona Therapeutics Inc (ABEO) is $270.41M

What is Abeona Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Abeona Therapeutics Inc is ABEO

How Can Investors Use Abeona Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Abeona Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Abeona Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Abeona Therapeutics Inc shares for Indian investors?

When investing in Abeona Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Abeona Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Abeona Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Abeona Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Abeona Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top